On January 9, 2026, USPTO Director John A. Squires designated four recent discretionary-denial rulings as precedential and ...

Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.

Avacta Therapeutics (AIM: AVCT), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, has published a trading update for the year ended ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued ...

FastWave Medical used 2025 to make uncommon progress for an early-stage company, advancing not one but two differentiated IVL ...

Avacta Therapeutics said on Wednesday that it has received clearance from the US Food and Drug Administration for the ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...

Munich Airport opens its new Terminal 1 Pier in April, adding non-Schengen capacity, premium lounges, and modernized ...

Avacta Therapeutics (AIM: AVCT), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated oncology delivery platform ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing ...

Pawankumar Suresh enhances early-stage drug research processes, ensuring regulatory compliance through effective systems and vendor governance.

MoD to release revised DAP 2020 draft, cutting procurement time, promoting indigenous content, AI and quantum tech, and ...